MassChallenge Startups Create Impact


Startups Accelerated


Funding Raised


Revenue Generated


Jobs Created

Our startups

Be inspired. Search our startups.

Met Syn Lysine Ltd.
Met Syn Lysine Ltd.

In individuals with Obesity/Metabolic Syndrome, there is a chronic elevation of blood Insulin levels, which in turn increases Insulin Resistance, causing an increase in appetite and over-eating, thus creating a vicious cycle.
We will cut-off this vicious cycle by inhibiting the Insulin secretion, and reducing it, using an analogue of the hormone Somatostain which naturaly inhibits Insulin after a meal.
There is a clear-cut correlation between inhibiting Insulin secretion and weight loss.
Cyclic oral Somatostatin analogue to reverse the Metabolic Syndrome will lower weight, blood sugar(Diabetes),lipids & blood pressure.

Connect with Met Syn Lysine Ltd.


2020 Finalist Israel

Sub industry

Therapeutics (Pharma / Biotech)


Our mission is to equip bold entrepreneurs to disrupt the status quo and to create meaningful change.